Evidence map›Paper›PMID 26868429›Full record

ArticleScientific reports2016

Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.

José A G Agúndez, Elena García-Martín, Carmen Martínez, Julián Benito-León, Jorge Millán-Pascual, María Díaz-Sánchez, Patricia Calleja, Diana Pisa, Laura Turpín-Fenoll, Hortensia Alonso-Navarro and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Oxidative Stress Markers in Multiple Sclerosis.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. The prognostic and therapeutic potential of HO-1 in leukemia and MDS.Cell communication and signaling : CCS · 2023
    Review
  9. Association betweenInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Association of HMOX-1 rs2071747 with sporadic Parkinson's disease in southern Han Chinese.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  12. Antioxidants (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

José A G AgúndezDepartment of Pharmacology, University of Extremadura, Cáceres, SPAIN.
Elena García-MartínDepartment of Pharmacology, University of Extremadura, Cáceres, SPAIN.
Carmen MartínezDepartment of Pharmacology, University of Extremadura, Badajoz, SPAIN.
Julián Benito-LeónCIBERNED,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, SPAIN.
Jorge Millán-PascualSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan (Ciudad Real), SPAIN.
María Díaz-SánchezService of Neurology, Hospital Universitario Doce de Octubre, Madrid, SPAIN.
Patricia CallejaService of Neurology, Hospital Universitario Doce de Octubre, Madrid, SPAIN.
Diana PisaCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Facultad de Ciencias, Universidad Autónoma, Cantoblanco, Madrid, SPAIN.
Laura Turpín-FenollSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan (Ciudad Real), SPAIN.
Hortensia Alonso-NavarroSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan (Ciudad Real), SPAIN.
Pau PastorCIBERNED,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, SPAIN.
Sara Ortega-CuberoCIBERNED,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, SPAIN.
Lucía Ayuso-PeraltaDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias". Universidad de Alcalá, Alcalá de Henares (Madrid), SPAIN.
Dolores TorrecillasDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias". Universidad de Alcalá, Alcalá de Henares (Madrid), SPAIN.
Esteban García-AlbeaDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias". Universidad de Alcalá, Alcalá de Henares (Madrid), SPAIN.
José Francisco Plaza-NietoSection of Neurology, Hospital Universitario del Sureste. Arganda del Rey (Madrid), SPAIN.
Félix Javier Jiménez-JiménezDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias". Universidad de Alcalá, Alcalá de Henares (Madrid), SPAIN.
Universidad de Alcalá · ESUniversidad Complutense de Madrid · ESUniversidad de Extremadura · ESHospital Universitario del Sureste · ESCentro de Investigación Biomédica en Red · ESConsejo Superior de Investigaciones Científicas · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several neurochemical, neuropathological, and experimental data suggest a possible role of oxidative stress in the ethiopathogenesis of multiple sclerosis(MS). Heme-oxygenases(HMOX) are an important defensive mechanism against oxidative stress, and HMOX1 is overexpressed in the brain and spinal cord of MS patients and in experimental autoimmune encephalomyelitis(EAE). We analyzed whether common polymorphisms affecting the HMOX1 and HMOX2 genes are related with the risk to develop MS. We analyzed the distribution of genotypes and allelic frequencies of the HMOX1 rs2071746, HMOX1 rs2071747, HMOX2 rs2270363, and HMOX2 rs1051308 SNPs, as well as the presence of Copy number variations(CNVs) of these genes in 292 subjects MS and 533 healthy controls, using TaqMan assays. The frequencies of HMOX2 rs1051308AA genotype and HMOX2 rs1051308A and HMOX1 rs2071746A alleles were higher in MS patients than in controls, although only that of the SNP HMOX2 rs1051308 in men remained as significant after correction for multiple comparisons. None of the studied polymorphisms was related to the age at disease onset or with the MS phenotype. The present study suggests a weak association between HMOX2 rs1051308 polymorphism and the risk to develop MS in Spanish Caucasian men and a trend towards association between the HMOX1 rs2071746A and MS risk.

Indexed as

Genetic Predisposition to DiseaseAdultAllelesFemaleGene FrequencyHealthy VolunteersHeme Oxygenase-1Heme Oxygenase (Decyclizing)HumansMaleMultiple SclerosisPolymorphism, Single NucleotideRisk FactorsHeme Oxygenase-1heme oxygenase-2Heme Oxygenase (Decyclizing)

Identifiers

PMID26868429
PMCPMC4751624
OpenAlexW2297848299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.